Search research articles
Contact Us
Filters
Showing results (41-50 of 71) with videos related to
Page
of 8
Sort By:
Boletin Medico Del Hospital Infantil De Mexico
|
December 1, 1993
[Prenatal ultrasonographic diagnosis and early surgical treatment in choledochal cyst]
G Porras-Ramírez, M H Hernández-Herrera, M A Soto-Sánchez, et al.
Journal of Clinical Pharmacology
|
February 8, 2002
Effect of rofecoxib on the pharmacokinetics of chronically administered oral contraceptives in healthy female volunteers
Jules I Schwartz, Peggy H Wong, Arturo G Porras, et al.
The European Journal of Neuroscience
|
March 27, 2001
Neurochemical and electrophysiological evidence that 5-HT4 receptors exert a state-dependent facilitatory control in vivo on nigrostriatal, but not mesoaccumbal, dopaminergic function
G Lucas, V Di Matteo, P De Deurwaerdère, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 1, 1995
Cyclospora cayetanensis infection in patients with and without AIDS: biliary disease as another clinical manifestation
J Sifuentes-Osornio, G Porras-Cortés, R P Bendall, et al.
Gaceta Medica De Mexico
|
January 1, 1992
[Genetic disorders in sexual differentiation in humans]
F Salamanca-Gómez, S H Kofman-Alfaro, S A Cuevas-Covarrubias, et al.
Journal of Clinical Pharmacology
|
March 6, 2003
Effect of rofecoxib on prednisolone and prednisone pharmacokinetics in healthy subjects
Jules I Schwartz, Saurabh Mukhopadhyay, Arturo G Porras, et al.
Journal of Clinical Pharmacology
|
October 1, 2003
An evaluation of the dose-dependent inhibition of CYP1A2 by rofecoxib using theophylline as a CYP1A2 probe
Kenneth Bachmann, Donald White, Luis Jauregui, et al.
Journal of Clinical Pharmacology
|
October 5, 2001
Dose proportionality of oral etoricoxib, a highly selective cyclooxygenase-2 inhibitor, in healthy volunteers
N G Agrawal, A G Porras, C Z Matthews, et al.
Journal of Clinical Pharmacology
|
January 6, 2001
Effect of rofecoxib on the pharmacokinetics of digoxin in healthy volunteers
J I Schwartz, M De Smet, P J Larson, et al.
Clinical Pharmacology and Therapeutics
|
September 1, 1995
Studies of the oral bioavailability of alendronate
B J Gertz, S D Holland, W F Kline, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 71) with videos related to
Sort By:
Page
of 8
Boletin Medico Del Hospital Infantil De Mexico
|
December 1, 1993
[Prenatal ultrasonographic diagnosis and early surgical treatment in choledochal cyst]
G Porras-Ramírez, M H Hernández-Herrera, M A Soto-Sánchez, et al.
Journal of Clinical Pharmacology
|
February 8, 2002
Effect of rofecoxib on the pharmacokinetics of chronically administered oral contraceptives in healthy female volunteers
Jules I Schwartz, Peggy H Wong, Arturo G Porras, et al.
The European Journal of Neuroscience
|
March 27, 2001
Neurochemical and electrophysiological evidence that 5-HT4 receptors exert a state-dependent facilitatory control in vivo on nigrostriatal, but not mesoaccumbal, dopaminergic function
G Lucas, V Di Matteo, P De Deurwaerdère, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 1, 1995
Cyclospora cayetanensis infection in patients with and without AIDS: biliary disease as another clinical manifestation
J Sifuentes-Osornio, G Porras-Cortés, R P Bendall, et al.
Gaceta Medica De Mexico
|
January 1, 1992
[Genetic disorders in sexual differentiation in humans]
F Salamanca-Gómez, S H Kofman-Alfaro, S A Cuevas-Covarrubias, et al.
Journal of Clinical Pharmacology
|
March 6, 2003
Effect of rofecoxib on prednisolone and prednisone pharmacokinetics in healthy subjects
Jules I Schwartz, Saurabh Mukhopadhyay, Arturo G Porras, et al.
Journal of Clinical Pharmacology
|
October 1, 2003
An evaluation of the dose-dependent inhibition of CYP1A2 by rofecoxib using theophylline as a CYP1A2 probe
Kenneth Bachmann, Donald White, Luis Jauregui, et al.
Journal of Clinical Pharmacology
|
October 5, 2001
Dose proportionality of oral etoricoxib, a highly selective cyclooxygenase-2 inhibitor, in healthy volunteers
N G Agrawal, A G Porras, C Z Matthews, et al.
Journal of Clinical Pharmacology
|
January 6, 2001
Effect of rofecoxib on the pharmacokinetics of digoxin in healthy volunteers
J I Schwartz, M De Smet, P J Larson, et al.
Clinical Pharmacology and Therapeutics
|
September 1, 1995
Studies of the oral bioavailability of alendronate
B J Gertz, S D Holland, W F Kline, et al.
Page
of 8